Global Clinical Trial
-
{
- All
- News
- Videos
-
Russia Claims Breakthrough Vaccine Against New Ebola Strain
Russia has announced the development of a vaccine targeting a new Ebola strain linked to the ongoing Bundibugyo outbreak in Congo and Uganda. Experts say the move could strengthen global outbreak preparedness, though clinical data is awaited
-
New Tuberculosis Vaccines: Phase 3 Study Confirms Safety, But It May Not Protect Against All Forms Of Infection
The two new tuberculosis vaccines could be safe for use in adults and children in India but may not provide protection against all forms of the infectious bacterial disease, according to phase-3 trial results published in The British Medical Journal.
-
Asthma Treatment Breakthrough: Could This Single Drug End Inhaler Dependency For Millions?
A new asthma drug named Lunsekimig could be the answer for millions who remain dependent on inhalers. Here is what the phase 2 trials of the drug signal, and why it shows promise for better asthma management.
-
India Launches Clinical Study Integrating Traditional Ayurveda With Modern Tuberculosis Treatments
India on Tuesday launched a first-of-its-kind global clinical study to scientifically evaluate traditional Ayurveda as an adjunct to modern tuberculosis (TB) treatments.
-
India's BioE3 Policy Is Advancing GeneEditing And Cell Therapy: Minister
The first-in-human Phase-I clinical trial for gene therapy of Hemophilia A has shown clinically significant outcomes.
-
India Close To Launching Dengue Vaccine, Final Trials Underway
As dengue surges globally, an Indian vaccine candidate has entered the final stage of testing, raising hopes for one of the world's first single-dose shots.
-
Nipah Breakthrough: Japan To Begin First Human Vaccine Trial In April
A team of researchers in Japan has announced a clinical trial to confirm a vaccine's efficacy against the deadly Nipah virus in humans.
-
South Korea Develops AI Model For A Custom Cancer Vaccine
A joint research team of the Korea Advanced Institute of Science and Technology (KAIST) and domestic biotechnology firm Neogenlogic have developed a new artificial intelligence.
-
US Aid Cuts Halt HIV Vaccine Research In South Africa, With Global Impact
Just a week had remained before scientists in South Africa were to begin clinical trials of an HIV vaccine, and hopes were high for another step toward limiting one of history's deadliest pandemics. Then the email arrived.
-
Revolutionary New Drug Offers 99.9% Protection Against HIV
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high costs may limit its global impact.
-
Marburg Virus Outbreak in Rwanda: Spread, Symptoms, and Global Concerns
Rwanda's first Marburg virus outbreak has resulted in 11 deaths. Health officials are responding with clinical trials to address the spread. The virus, related to Ebola, can cause severe haemorrhagic fever and is often linked to fruit bats.
-
US Eager To Involve India In Covid Clinical Trials: Dr Fauci
America's top infectious disease specialist Dr Anthony Fauci on Thursday said his country is eager to involve Indian investigators in global clinical trials to evaluate the safety and efficacy of COVID-19 therapeutics.
-
"Not Rocket Science...": AIIMS Chief On Adar Poonawalla, Vaccine Supply
Predicting the global clamour for coronavirus vaccines - even as early as six months ago, when several candidates were still in late-stage clinical trials - could not have been "rocket science", AIIMS chief Dr Randeep Guleria told NDTV Friday night
-
AstraZeneca-Oxford First To Publish Final-Stage Vaccine Trial Results
Oxford University and AstraZeneca on Tuesday became the first Covid-19 vaccine makers to publish final-stage clinical trial data in a scientific journal, clearing a key hurdle in the global race to produce safe and effective drugs for the coronavirus.
-
Dr. Reddy's Shuts Key Plans, Isolates Data Centre Services After Cyberattack
Pharmaceutical giant Dr. Reddy's Laboratories today said that it had isolated all its data centre services as a preventive measure following a cyberattack. The drug maker had shut its key plants globally due to the breach at its servers, ET Now had reported, citing sources.
-
Russia Claims Breakthrough Vaccine Against New Ebola Strain
Russia has announced the development of a vaccine targeting a new Ebola strain linked to the ongoing Bundibugyo outbreak in Congo and Uganda. Experts say the move could strengthen global outbreak preparedness, though clinical data is awaited
-
New Tuberculosis Vaccines: Phase 3 Study Confirms Safety, But It May Not Protect Against All Forms Of Infection
The two new tuberculosis vaccines could be safe for use in adults and children in India but may not provide protection against all forms of the infectious bacterial disease, according to phase-3 trial results published in The British Medical Journal.
-
Asthma Treatment Breakthrough: Could This Single Drug End Inhaler Dependency For Millions?
A new asthma drug named Lunsekimig could be the answer for millions who remain dependent on inhalers. Here is what the phase 2 trials of the drug signal, and why it shows promise for better asthma management.
-
India Launches Clinical Study Integrating Traditional Ayurveda With Modern Tuberculosis Treatments
India on Tuesday launched a first-of-its-kind global clinical study to scientifically evaluate traditional Ayurveda as an adjunct to modern tuberculosis (TB) treatments.
-
India's BioE3 Policy Is Advancing GeneEditing And Cell Therapy: Minister
The first-in-human Phase-I clinical trial for gene therapy of Hemophilia A has shown clinically significant outcomes.
-
India Close To Launching Dengue Vaccine, Final Trials Underway
As dengue surges globally, an Indian vaccine candidate has entered the final stage of testing, raising hopes for one of the world's first single-dose shots.
-
Nipah Breakthrough: Japan To Begin First Human Vaccine Trial In April
A team of researchers in Japan has announced a clinical trial to confirm a vaccine's efficacy against the deadly Nipah virus in humans.
-
South Korea Develops AI Model For A Custom Cancer Vaccine
A joint research team of the Korea Advanced Institute of Science and Technology (KAIST) and domestic biotechnology firm Neogenlogic have developed a new artificial intelligence.
-
US Aid Cuts Halt HIV Vaccine Research In South Africa, With Global Impact
Just a week had remained before scientists in South Africa were to begin clinical trials of an HIV vaccine, and hopes were high for another step toward limiting one of history's deadliest pandemics. Then the email arrived.
-
Revolutionary New Drug Offers 99.9% Protection Against HIV
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high costs may limit its global impact.
-
Marburg Virus Outbreak in Rwanda: Spread, Symptoms, and Global Concerns
Rwanda's first Marburg virus outbreak has resulted in 11 deaths. Health officials are responding with clinical trials to address the spread. The virus, related to Ebola, can cause severe haemorrhagic fever and is often linked to fruit bats.
-
US Eager To Involve India In Covid Clinical Trials: Dr Fauci
America's top infectious disease specialist Dr Anthony Fauci on Thursday said his country is eager to involve Indian investigators in global clinical trials to evaluate the safety and efficacy of COVID-19 therapeutics.
-
"Not Rocket Science...": AIIMS Chief On Adar Poonawalla, Vaccine Supply
Predicting the global clamour for coronavirus vaccines - even as early as six months ago, when several candidates were still in late-stage clinical trials - could not have been "rocket science", AIIMS chief Dr Randeep Guleria told NDTV Friday night
-
AstraZeneca-Oxford First To Publish Final-Stage Vaccine Trial Results
Oxford University and AstraZeneca on Tuesday became the first Covid-19 vaccine makers to publish final-stage clinical trial data in a scientific journal, clearing a key hurdle in the global race to produce safe and effective drugs for the coronavirus.
-
Dr. Reddy's Shuts Key Plans, Isolates Data Centre Services After Cyberattack
Pharmaceutical giant Dr. Reddy's Laboratories today said that it had isolated all its data centre services as a preventive measure following a cyberattack. The drug maker had shut its key plants globally due to the breach at its servers, ET Now had reported, citing sources.
